Literature DB >> 19187368

'Blood On The Tracks' from corpora lutea to endometriomas.

P Vercellini1, E Somigliana, P Vigano, A Abbiati, G Barbara, L Fedele.   

Abstract

OBJECTIVE: To detect a direct transition from a haemorrhagic corpus luteum to an endometriotic cyst by serial transvaginal ultrasonographic scans.
DESIGN: Prospective observational study.
SETTING: An academic tertiary care and referral centre for women with endometriosis. POPULATION: One hundred and nine women younger than 40 years, with regular menstrual cycles, undergoing first-line surgery for endometriomas, and not wanting postoperative oral contraception.
METHODS: Three-monthly transvaginal ultrasonography during the luteal phase for 2 years after surgery. MAIN OUTCOME MEASURE: Sonographic identification of progression from a haemorrhagic corpus luteum to a recurrent endometriotic cyst.
RESULTS: A haemorrhagic corpus luteum was identified in 13 women. Serial ultrasonographic scans demonstrated transition to an endometriotic cyst in 11 (85%) instances and resorption in two. A unilateral endometriotic cyst without previous detection of a cystic corpus luteum was observed in 14 women.
CONCLUSIONS: Bleeding from a corpus luteum appears to be a critical event in the development of endometriomas.

Entities:  

Mesh:

Year:  2009        PMID: 19187368     DOI: 10.1111/j.1471-0528.2008.02055.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  10 in total

1.  Ovarian endometriosis: the nemesis of eggs.

Authors:  Serdar E Bulun
Journal:  Fertil Steril       Date:  2014-03-06       Impact factor: 7.329

Review 2.  Endometriosis.

Authors:  Serdar E Bulun; Bahar D Yilmaz; Christia Sison; Kaoru Miyazaki; Lia Bernardi; Shimeng Liu; Amanda Kohlmeier; Ping Yin; Magdy Milad; JianJun Wei
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

3.  Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.

Authors:  Seung-Hye Choi; Sung Eun Kim; Hyun Hye Lim; Dong-Yun Lee; DooSeok Choi
Journal:  J Korean Med Sci       Date:  2022-07-04       Impact factor: 5.354

Review 4.  Endometriosis: pathogenesis and treatment.

Authors:  Paolo Vercellini; Paola Viganò; Edgardo Somigliana; Luigi Fedele
Journal:  Nat Rev Endocrinol       Date:  2013-12-24       Impact factor: 43.330

5.  MUC2 polymorphisms are associated with endometriosis development and infertility: a case-control study.

Authors:  Cherry Yin-Yi Chang; Yi Chen; Wu-Chou Lin; Chih-Mei Chen; Chih-Ping Chen; Shan-Chih Lee; Jim Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2012-03-15       Impact factor: 2.103

6.  Transvaginal endoscopy and small ovarian endometriomas: unravelling the missing link?

Authors:  S Gordts; P Puttemans; Sy Gordts; M Valkenburg; I Brosens; R Campo
Journal:  Gynecol Surg       Date:  2013-10-17

7.  Free large sized intra-abdominal endometrioma in a postmenopausal woman: a case report.

Authors:  Antoine Naem; Anwar Shamandi; Ali Al-Shiekh; Bayan Alsaid
Journal:  BMC Womens Health       Date:  2020-09-03       Impact factor: 2.809

Review 8.  Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis.

Authors:  R Wattanayingcharoenchai; S Rattanasiri; C Charakorn; J Attia; A Thakkinstian
Journal:  BJOG       Date:  2020-07-14       Impact factor: 6.531

9.  Correlation of Serum Anti-Mullerian Hormone (AMH) Level on Ovarian Volume in Women with Endometrioma.

Authors:  Dodi Suardi; Wiryawan Permadi; Tono Djuwantono; Yudi Mulyana Hidayat; Hartanto Bayuaji; Gusti Putu Edo Gautama
Journal:  Int J Gen Med       Date:  2021-01-06

Review 10.  The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life.

Authors:  Giovanni Grandi; Angela Toss; Laura Cortesi; Laura Botticelli; Annibale Volpe; Angelo Cagnacci
Journal:  Biomed Res Int       Date:  2015-08-30       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.